ADENOSINE INJECTION
ADENOSINE INJECTION
Approved
DIN Number
02267659
Drug Class
Human
Market Date
Mar 27, 2007
Company
HC
fresenius kabi canada ltd
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02267659
AIG Number0113219001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
C01EB10 ADENOSINE
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification24:04.04.24
Health Canada Classification
ACTIVE INGREDIENTS (1)
ADENOSINEActive
Strength: 3 MG / ML
Monograph: ADENOSINE